Bantilan, Teotima M.
HRN: 11-67-41 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/07/2022
CEFTRIAXONE 1G (VIAL)
11/07/2022
11/13/2022
IV
2gm
Q24
Cap MR
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes